Cytosorbents Corporation (CTSO)

Cytosorbents Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Cytosorbents stock have an average target of 4.67, with a low estimate of 1.00 and a high estimate of 10. The average target predicts an increase of 410.38% from the current stock price of 0.92.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$1.00	$4.67	$3.00	$10
Change	+9.29%	+410.38%	+227.87%	+992.90%

* Price targets were last updated on Nov 12, 2024.

Analyst Ratings

The average analyst rating for Cytosorbents stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	3	3	3	2	2	2
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+992.90%	Nov 12, 2024
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $1	Hold	Reiterates	$1	+9.29%	Nov 11, 2024
Jason Kolbert EF Hutton	EF Hutton	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+992.90%	Nov 8, 2024
Jason Kolbert EF Hutton	EF Hutton	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+992.90%	Nov 4, 2024
Jason Kolbert EF Hutton	EF Hutton	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+992.90%	Oct 22, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

39.29M

Increased by 8.08%

from 36.35M

Revenue Next Year

44.32M

Increased by 12.80%

from 39.29M

EPS This Year

-0.31

from -0.64

EPS Next Year

-0.21

from -0.31

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	24.95M	41.00M	43.17M	34.69M	36.35M	39.29M	44.32M	53.97M
Revenue Growth	10.87%	64.35%	5.27%	-19.64%	4.79%	8.08%	12.80%	21.77%
EPS	-0.60	-0.20	-0.57	-0.75	-0.64	-0.31	-0.21	-0.09
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028	2029
High	40.7M	47.8M	61.9M
Avg	39.3M	44.3M	54.0M
Low	37.4M	41.2M	47.5M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028	2029
High	12.1%	21.7%	39.7%
Avg	8.1%	12.8%	21.8%
Low	2.9%	4.8%	7.2%

EPS Forecast

EPS	2024	2025	2026
High	-0.32	-0.15	0.02
Avg	-0.31	-0.21	-0.09
Low	-0.29	-0.26	-0.14

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.